Validation of the Khorana score for predicting venous thromboembolism in 40 218 patients with cancer initiating chemotherapy
Sign Up to like & getrecommendations! Published in 2022 at "Blood Advances"
DOI: 10.1182/bloodadvances.2021006484
Abstract: Key Points The Khorana score did risk-stratify cancer patients according to 6-month risk of VTE, but only for some cancer types. Absolute risk estimates were lower than previously reported, questioning the benefit of ambulatory thromboprophylaxis… read more here.
Keywords: validation khorana; venous thromboembolism; predicting venous; score predicting ... See more keywords